Table of contents
Lisa A. Snider(National Institutes of Health), Neal R. Swerdlow, Kristi A. Sacco(Yale University), Jordan B. Hiller, Yansheng Du(Indiana University School of Medicine), Jill M. Hooley(Harvard University Press), Brigid S. Boland, Marcia J. Slattery(University of Wisconsin–Madison), Susan E. Swedo(National Institute of Mental Health), Melissa M. Dudas, Stefan Teipel(German Center for Neurodegenerative Diseases), Jennifer C. Vessicchio, Gregory A. Light(University of California San Diego), Jack G. Modell, Daniel F. Connor, Angelo Termine, Richard Dodel(University of Duisburg-Essen), Harald Hampel(Sorbonne Université), Christina Fischer-Schulz, Aisha A. Seyal, Andreas Bergmann, James J. Hudziak(University of Vermont), Staci A. Gruber, Tony P. George(Centre for Addiction and Mental Health), Lorraine Lougee(Unknown), Joel Ellwanger, Nathalie Richard, Joyce Sprock, Joseph P. Horrigan, Paul Grant(National Institute of Mental Health), S. Brettschneider, Katharina Bu, Hans-Ju ̈rgen Möller, Nils G. Morgenthaler, David Braff(University of California San Diego), Deborah Yurgelun‐Todd(VA Rocky Mountain Network), Laurie Scott, Norman E. Rosenthal(MDS Associates (United States)), Margaret Fonder, Kenneth D. Hampton, Barbara R. Haight, Timothy E. Wilens(Massachusetts General Hospital)
Cited by 0
Related Papers
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
|Neurology|2016|1.9k
The Amyloid-β Pathway in Alzheimer’s Disease
|Molecular Psychiatry|2021|1.8k